Cargando…

Exploitation of Marine Molecules to Manage Alzheimer’s Disease

Neurodegenerative diseases are sociosanitary challenges of today, as a result of increased average life expectancy, with Alzheimer’s disease being one of the most prevalent. This pathology is characterized by brain impairment linked to a neurodegenerative process culminating in cognitive decline and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Marisa, Seijas, Paula, Otero, Paz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307759/ https://www.ncbi.nlm.nih.gov/pubmed/34203244 http://dx.doi.org/10.3390/md19070373

Ejemplares similares

Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease
por: Bilal, Muhammad, et al.
Publicado: (2021)

Emerging Marine Biotoxins in European Waters: Potential Risks and Analytical Challenges
por: Otero, Paz, et al.
Publicado: (2022)

Marine Metagenomics: New Tools for the Study and Exploitation of Marine Microbial Metabolism
por: Kennedy, Jonathan, et al.
Publicado: (2010)

Exploiting Citrus aurantium seeds and their secondary metabolites in the management of Alzheimer disease
por: Abou Baker, Doha H., et al.
Publicado: (2020)

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
por: Dionisio-Santos, Dawling A., et al.
Publicado: (2019)

Hypoglycaemic Molecules for the Management of Diabetes Mellitus from Marine Sources
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2023)

Anti-Alzheimer’s Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential
por: Kabir, Md. Tanvir, et al.
Publicado: (2021)

Exploiting Common Aspects of Obesity and Alzheimer’s Disease
por: Tabassum, Sidra, et al.
Publicado: (2020)

Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
por: Martins, Márcia, et al.
Publicado: (2020)

Functional genetic diversity in an exploited marine species and its relevance to fisheries management
por: Petrou, Eleni L., et al.
Publicado: (2021)

Exploitation of marine bacteria for production of gold nanoparticles
por: Sharma, Nishat, et al.
Publicado: (2012)

The transboundary nature of the world’s exploited marine species
por: Palacios-Abrantes, Juliano, et al.
Publicado: (2020)

Marine-Derived Compounds with Anti-Alzheimer’s Disease Activities
por: Hafez Ghoran, Salar, et al.
Publicado: (2021)

New Drugs from Marine Organisms in Alzheimer’s Disease
por: Russo, Patrizia, et al.
Publicado: (2015)

Seaweed-Derived Proteins and Peptides: Promising Marine Bioactives
por: Echave, Javier, et al.
Publicado: (2022)

Small Molecules of Marine Origin as Potential Anti-Glioma Agents
por: Alves, Ana, et al.
Publicado: (2021)

Alzheimer’s Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore
por: Botelho, Maria João, et al.
Publicado: (2022)

Exploiting biodiversity in the marine environment: a personal perspective
por: Gutnick, David
Publicado: (2010)

Taylor's law and body size in exploited marine ecosystems
por: Cohen, Joel E, et al.
Publicado: (2012)

Exploitation drives an ontogenetic-like deepening in marine fish
por: Frank, Kenneth T., et al.
Publicado: (2018)

Integrating spatial indicators in the surveillance of exploited marine ecosystems
por: Rufino, Marta Mega, et al.
Publicado: (2018)

HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules
por: Saito, Akatsuki, et al.
Publicado: (2021)

Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer’s Disease
por: Rampa, Angela, et al.
Publicado: (2018)

Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
por: Afrasiabi, Kambiz, et al.
Publicado: (2020)

Marine-derived microbes and molecules for drug discovery
por: Tanaka, Yoshimasa, et al.
Publicado: (2022)

Synaptic Cell Adhesion Molecules in Alzheimer's Disease
por: Leshchyns'ka, Iryna, et al.
Publicado: (2016)

Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases
por: Grosso, Clara, et al.
Publicado: (2014)

Investigation of Marine-Derived Fungal Diversity and Their Exploitable Biological Activities
por: Hong, Joo-Hyun, et al.
Publicado: (2015)

Reduced Global Genetic Differentiation of Exploited Marine Fish Species
por: Gandra, Miguel, et al.
Publicado: (2020)

Diversity, distribution and intrinsic extinction vulnerability of exploited marine bivalves
por: Huang, Shan, et al.
Publicado: (2023)

Antioxidant Molecules from Marine Fungi: Methodologies and Perspectives
por: Vitale, Giovanni Andrea, et al.
Publicado: (2020)

Fluorinated Molecules and Nanotechnology: Future ‘Avengers’ against the Alzheimer’s Disease?
por: Dabur, Meghna, et al.
Publicado: (2020)

Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
por: Tamburini, Bartolo, et al.
Publicado: (2023)

Application of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
por: Hu, Di, et al.
Publicado: (2023)

Benefits and Drawbacks of Ultrasound-Assisted Extraction for the Recovery of Bioactive Compounds from Marine Algae
por: Carreira-Casais, Anxo, et al.
Publicado: (2021)

Tenascin-C: Exploitation and collateral damage in cancer management
por: Spenlé, Caroline, et al.
Publicado: (2015)

Fast and behavior-selective exploitation of a marine fish targeted by anglers
por: Alós, Josep, et al.
Publicado: (2016)

Fitness consequences of fish circadian behavioural variation in exploited marine environments
por: Martorell-Barceló, Martina, et al.
Publicado: (2018)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

Prospects of Marine Sterols against Pathobiology of Alzheimer’s Disease: Pharmacological Insights and Technological Advances
por: Rahman, Md. Ataur, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ek0563m74ohftoccccbkgaj016